Liquid nitrogen in the treatment of skin diseases.

Liquid nitrogen in the treatment of skin diseases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Liquid nitrogen in the treatment of skin diseases. Abstract Text:

Liquid nitrogen is a satisfactory freezing agent in the treatment of such skin diseases as warts, keratoses, superficial hemangiomas, leukoplakia, keloids, superficial scarring and dermatitis venenata. It is available and easily applied. Its use is described and the results of treatment in 154 cases of warts are presented.

Liquid nitrogen in the treatment of skin diseases. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Liquid nitrogen in the treatment of skin diseases. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: California medicine

VOLUME: 72

Page Numbers: 153-5

Journal Abbreviation:

ISSN: 0008-1264

DAY: 4

MONTH: Mar

YEAR: 1950

Liquid nitrogen in the treatment of skin diseases. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 410260

Liquid nitrogen in the treatment of skin diseases. Keywords Mesh Terms:

KEYWORDS: Skin

MESH TERMS:

Chemical & Substance for Abstract: Liquid nitrogen in the treatment of skin diseases. Information

Substance Name: Nitrogen

Registry Number: 7727-37-9

Grant and Affiliation Information for Liquid nitrogen in the treatment of skin diseases.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Calif Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Liquid nitrogen in the treatment of skin diseases Related Publications

• Anal comedos and pruritus ani.
• Autosensitization dermatitis; report of five cases and protocol of an experiment.
• CAPILLARY ANEURYSMS OF THE SKIN.
• Capillary aneurysms.
• Detection of fibrin(ogen) degradation products by a latex clumping method.
• Eyelid tumors.
• Liquid nitrogen in the treatment of skin diseases.
• Scabicidal Drugs: An Experimental Study.
• Sustained-release fampridine for symptomatic treatment of multiple sclerosis.
• The effect of parenteral nutrition with different lipid emulsions on platelets.
• The latex flocculation inhibition test for the detection of fibrin(ogen) degradation products.
• Thrombotest method for the control of anticoagulant therapy.
• Traumatic Epithelial Cysts.